We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

10 hedge funds and large institutions have $496K invested in Alterity Therapeutics in 2013 Q2 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+10
Holders Change %
–
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GBA
1
Garrison Bradford & Associates
New York
$199K +$194K +1,430 New
FC
2
FIC Capital
New York
$120K +$117K +860 New
AG
3
Aperio Group
California
$69K +$66.9K +493 New
ARTA
4
A.R.T. Advisors
New York
$31K +$30.3K +223 New
KCG
5
Knight Capital Group
$27K +$26.5K +195 New
Bank of America
6
Bank of America
North Carolina
$21K +$20.4K +150 New
Wells Fargo
7
Wells Fargo
California
$12K +$11.3K +83 New
TRCT
8
Tower Research Capital (TRC)
New York
$11K +$11K +81 New
Ameriprise
9
Ameriprise
Minnesota
$5K +$5.29K +39 New
Creative Planning
10
Creative Planning
Kansas
$1K +$1.09K +8 New

ATHE Hedge Fund Activity: Q2 2013 in Review

10 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q2 2013, worth a combined $496K.

Buyers outnumbered sellers: 10 funds opened new ATHE positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.

  • 10 institutional investors held Alterity Therapeutics (ATHE) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $496K of Alterity Therapeutics stock for Q2 2013.
  • 10 funds opened new Alterity Therapeutics positions in Q2 2013 and 0 closed out, a net change of +10 holders.

Based on aggregated 13F filings for Q2 2013.